$TBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Translate Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Translate Bio, Inc.. Get notifications about new insider transactions in Translate Bio, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2021 | TBIO | Translate Bio, Inc ... | Meyer Robert J. | Director | Option Exercise | A | 20.43 | 20,000 | 408,600 | 20,000 | |
| Jun 16 2021 | TBIO | Translate Bio, Inc ... | Hughes Owen | Director | Option Exercise | A | 20.43 | 20,000 | 408,600 | 20,000 | |
| Apr 20 2021 | TBIO | Translate Bio, Inc ... | Smith Brendan | Chief Financial Off ... | Option Exercise | A | 19.23 | 201,800 | 3,880,614 | 201,800 | |
| Apr 20 2021 | TBIO | Translate Bio, Inc ... | Smith Brendan | Chief Financial Off ... | Option Exercise | A | 19.23 | 201,800 | 3,880,614 | 201,800 | |
| Apr 09 2021 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Option Exercise | M | 7.39 | 9,026 | 66,702 | 1,071,009 | |
| Apr 09 2021 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Buy | M | 7.39 | 9,026 | 66,702 | 503,321 | 494.3 K to 503.3 K (+1.83 %) |
| Mar 23 2021 | TBIO | Translate Bio, Inc ... | Sutherland Everett Rand | President | Option Exercise | A | 16.37 | 300,000 | 4,911,000 | 300,000 | |
| Mar 09 2021 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Option Exercise | A | 23.82 | 325,000 | 7,741,500 | 325,000 | |
| Mar 09 2021 | TBIO | Translate Bio, Inc ... | Wooster Richard | Chief Scientific Of ... | Option Exercise | A | 23.82 | 70,000 | 1,667,400 | 70,000 | |
| Mar 09 2021 | TBIO | Translate Bio, Inc ... | Barbier Ann | Chief Medical Offic ... | Option Exercise | A | 23.82 | 70,000 | 1,667,400 | 70,000 | |
| Mar 09 2021 | TBIO | Translate Bio, Inc ... | Burgess Paul D. | Chief Operating Off ... | Option Exercise | A | 23.82 | 90,000 | 2,143,800 | 90,000 | |
| Jan 14 2021 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Option Exercise | M | 8.34 | 1 | 8 | 89,996 | |
| Jan 14 2021 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Option Exercise | M | 7.39 | 5,638 | 41,665 | 1,080,035 | |
| Jan 14 2021 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Buy | M | 8.34 | 1 | 8 | 494,205 | 494.2 K to 494.2 K (0.00 %) |
| Jan 14 2021 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Buy | M | 7.39 | 5,638 | 41,665 | 494,204 | 488.6 K to 494.2 K (+1.15 %) |
| Dec 23 2020 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 25.88 | 2,700 | 69,883 | 43,940 | 46.6 K to 43.9 K (-5.79 %) |
| Dec 23 2020 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 25.04 | 79,865 | 1,999,987 | 46,640 | 126.5 K to 46.6 K (-63.13 %) |
| Dec 23 2020 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 25.50 | 56,536 | 1,441,928 | 126,505 | 183 K to 126.5 K (-30.89 %) |
| Aug 27 2020 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 14.38 | 10,097 | 145,217 | 3,833,122 | 3.8 M to 3.8 M (-0.26 %) |
| Aug 27 2020 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 14.80 | 44,381 | 656,746 | 3,843,219 | 3.9 M to 3.8 M (-1.14 %) |
| Aug 27 2020 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 15.00 | 34,410 | 516,160 | 3,887,600 | 3.9 M to 3.9 M (-0.88 %) |
| Aug 27 2020 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 14.38 | 10,097 | 145,217 | 3,833,122 | 3.8 M to 3.8 M (-0.26 %) |
| Aug 27 2020 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 14.80 | 44,381 | 656,746 | 3,843,219 | 3.9 M to 3.8 M (-1.14 %) |
| Aug 27 2020 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Sell | S | 15.00 | 34,410 | 516,160 | 3,887,600 | 3.9 M to 3.9 M (-0.88 %) |
| Jun 30 2020 | TBIO | Translate Bio, Inc ... | Shire Human Genetic Therapies, ... | 10% Owner | Sell | S | 20.68 | 6,824,992 | 141,140,835 | 0 | 6.8 M to 0 (-100.00 %) |
| Jun 30 2020 | TBIO | Translate Bio, Inc ... | BAUPOST GROUP LLC/MA | 10% Owner | Buy | P | 22.00 | 500,000 | 11,000,000 | 18,044,239 | 17.5 M to 18 M (+2.85 %) |
| Jun 17 2020 | TBIO | Translate Bio, Inc ... | LYNCH DANIEL | Director | Option Exercise | A | 15.33 | 18,900 | 289,737 | 18,900 | |
| Jun 17 2020 | TBIO | Translate Bio, Inc ... | Beckman Daniella | Director | Option Exercise | A | 15.33 | 18,900 | 289,737 | 18,900 | |
| Jun 17 2020 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | A | 15.33 | 18,900 | 289,737 | 18,900 | |
| Jun 16 2020 | TBIO | Translate Bio, Inc ... | Plenge Robert M | Director | Option Exercise | A | 15.33 | 18,900 | 289,737 | 18,900 | |
| Jun 16 2020 | TBIO | Translate Bio, Inc ... | Meyer Robert J. | Director | Option Exercise | A | 15.33 | 18,900 | 289,737 | 18,900 | |
| Jun 16 2020 | TBIO | Translate Bio, Inc ... | Hughes Owen | Director | Option Exercise | A | 15.33 | 18,900 | 289,737 | 18,900 | |
| Jun 16 2020 | TBIO | Translate Bio, Inc ... | Demetri George | Director | Option Exercise | A | 15.33 | 18,900 | 289,737 | 18,900 | |
| Jun 05 2020 | TBIO | Translate Bio, Inc ... | Shire Human Genetic Therapies, ... | 10% Owner | Sell | S | 19.75 | 40,086 | 791,699 | 6,824,992 | 6.9 M to 6.8 M (-0.58 %) |
| Jun 03 2020 | TBIO | Translate Bio, Inc ... | Shire Human Genetic Therapies, ... | 10% Owner | Sell | S | 20.02 | 5,006 | 100,220 | 6,865,078 | 6.9 M to 6.9 M (-0.07 %) |
| Jun 03 2020 | TBIO | Translate Bio, Inc ... | Shire Human Genetic Therapies, ... | 10% Owner | Sell | S | 19.75 | 100,389 | 1,982,683 | 6,870,084 | 7 M to 6.9 M (-1.44 %) |
| Jun 03 2020 | TBIO | Translate Bio, Inc ... | Shire Human Genetic Therapies, ... | 10% Owner | Sell | S | 20.53 | 1,400 | 28,742 | 6,970,473 | 7 M to 7 M (-0.02 %) |
| Jun 03 2020 | TBIO | Translate Bio, Inc ... | Shire Human Genetic Therapies, ... | 10% Owner | Sell | S | 19.85 | 107,072 | 2,125,379 | 6,971,873 | 7.1 M to 7 M (-1.51 %) |
| Mar 05 2020 | TBIO | Translate Bio, Inc ... | Wooster Richard | Chief Scientific Of ... | Option Exercise | A | 7.66 | 150,000 | 1,149,000 | 150,000 | |
| Mar 05 2020 | TBIO | Translate Bio, Inc ... | Schroer John R. | Chief Financial Off ... | Option Exercise | A | 7.66 | 150,000 | 1,149,000 | 150,000 | |
| Mar 05 2020 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Option Exercise | A | 7.66 | 525,000 | 4,021,500 | 525,000 | |
| Mar 05 2020 | TBIO | Translate Bio, Inc ... | Burgess Paul D. | Chief Operating Off ... | Option Exercise | A | 7.66 | 150,000 | 1,149,000 | 150,000 | |
| Mar 05 2020 | TBIO | Translate Bio, Inc ... | Barbier Ann | Chief Medical Offic ... | Option Exercise | A | 7.66 | 150,000 | 1,149,000 | 150,000 | |
| Jul 15 2019 | TBIO | Translate Bio, Inc ... | Demetri George | Director | Option Exercise | A | 10.15 | 37,800 | 383,670 | 37,800 | |
| Jun 19 2019 | TBIO | Translate Bio, Inc ... | Plenge Robert M | Director | Option Exercise | A | 10.20 | 18,900 | 192,780 | 18,900 | |
| Jun 19 2019 | TBIO | Translate Bio, Inc ... | Meyer Robert J. | Director | Option Exercise | A | 10.20 | 18,900 | 192,780 | 18,900 | |
| Jun 19 2019 | TBIO | Translate Bio, Inc ... | LYNCH DANIEL | Director | Option Exercise | A | 10.20 | 18,900 | 192,780 | 18,900 | |
| Jun 19 2019 | TBIO | Translate Bio, Inc ... | Hughes Owen | Director | Option Exercise | A | 10.20 | 18,900 | 192,780 | 18,900 | |
| Jun 19 2019 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | A | 10.20 | 18,900 | 192,780 | 18,900 | |
| Jun 19 2019 | TBIO | Translate Bio, Inc ... | Beckman Daniella | Director | Option Exercise | A | 10.20 | 18,900 | 192,780 | 18,900 | |
| Apr 26 2019 | TBIO | Translate Bio, Inc ... | Wooster Richard | Chief Scientific Of ... | Option Exercise | A | 9.40 | 360,000 | 3,384,000 | 360,000 | |
| Apr 11 2019 | TBIO | Translate Bio, Inc ... | Plenge Robert M | Director | Option Exercise | A | 12.36 | 37,800 | 467,208 | 37,800 | |
| Mar 12 2019 | TBIO | Translate Bio, Inc ... | Schroer John R. | Chief Financial Off ... | Option Exercise | A | 7.95 | 125,000 | 993,750 | 125,000 | |
| Mar 12 2019 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Option Exercise | A | 7.95 | 500,000 | 3,975,000 | 500,000 | |
| Mar 12 2019 | TBIO | Translate Bio, Inc ... | Heartlein Michael | Chief Scientific Of ... | Option Exercise | A | 7.95 | 150,000 | 1,192,500 | 150,000 | |
| Mar 12 2019 | TBIO | Translate Bio, Inc ... | Fenton Brian | Chief Business Offi ... | Option Exercise | A | 7.95 | 90,000 | 715,500 | 90,000 | |
| Mar 12 2019 | TBIO | Translate Bio, Inc ... | Cloghessy Paula | Chief Human Resourc ... | Option Exercise | A | 7.95 | 60,000 | 477,000 | 60,000 | |
| Mar 12 2019 | TBIO | Translate Bio, Inc ... | Burgess Paul D. | Chief Legal Officer | Option Exercise | A | 7.95 | 150,000 | 1,192,500 | 150,000 | |
| Mar 12 2019 | TBIO | Translate Bio, Inc ... | Barbier Ann | Chief Medical Offic ... | Option Exercise | A | 7.95 | 125,000 | 993,750 | 125,000 | |
| Jul 05 2018 | TBIO | Translate Bio, Inc ... | Gallagher Brian M. Jr. | Director | Option Exercise | C | 0.00 | 2,525,253 | 0 | 0 | |
| Jul 05 2018 | TBIO | Translate Bio, Inc ... | Gallagher Brian M. Jr. | Director | Option Exercise | C | 0.00 | 7,222,797 | 0 | 0 | |
| Jul 05 2018 | TBIO | Translate Bio, Inc ... | Gallagher Brian M. Jr. | Director | Option Exercise | C | 0.00 | 9,300,000 | 0 | 0 | |
| Jul 05 2018 | TBIO | Translate Bio, Inc ... | Gallagher Brian M. Jr. | Director | Buy | P | 13.00 | 269,230 | 3,499,990 | 3,697,912 | 3.4 M to 3.7 M (+7.85 %) |
| Jul 05 2018 | TBIO | Translate Bio, Inc ... | Gallagher Brian M. Jr. | Director | Buy | C | 0.00 | 454,550 | 0 | 3,428,682 | 3 M to 3.4 M (+15.28 %) |
| Jul 05 2018 | TBIO | Translate Bio, Inc ... | Gallagher Brian M. Jr. | Director | Buy | C | 0.00 | 1,300,116 | 0 | 2,974,132 | 1.7 M to 3 M (+77.66 %) |
| Jul 05 2018 | TBIO | Translate Bio, Inc ... | Gallagher Brian M. Jr. | Director | Buy | C | 0.00 | 1,674,016 | 0 | 1,674,016 | 0 to 1.7 M |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | See Remarks | Option Exercise | C | 0.00 | 227,272 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | See Remarks | Option Exercise | C | 0.00 | 227,272 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | See Remarks | Buy | C | 0.00 | 40,909 | 0 | 40,909 | 0 to 40.9 K |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | See Remarks | Buy | C | 0.00 | 40,909 | 0 | 409,913 | 369 K to 409.9 K (+11.09 %) |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | MRL Ventures Fund LLC | 10% Owner | Option Exercise | C | 0.00 | 1,010,101 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | MRL Ventures Fund LLC | 10% Owner | Option Exercise | C | 0.00 | 9,259,259 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | MRL Ventures Fund LLC | 10% Owner | Buy | P | 13.00 | 25,000 | 325,000 | 1,873,503 | 1.8 M to 1.9 M (+1.35 %) |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | MRL Ventures Fund LLC | 10% Owner | Buy | C | 0.00 | 1,848,503 | 0 | 1,848,503 | 0 to 1.8 M |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 302,173 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 302,173 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,000,103 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,000,103 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,800,000 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,800,000 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,263,484 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,263,484 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,676,348 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,676,348 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,500,000 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,500,000 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Buy | C | 0.00 | 1,458,424 | 0 | 1,458,424 | 0 to 1.5 M |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Buy | C | 0.00 | 1,458,424 | 0 | 1,458,424 | 0 to 1.5 M |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Buy | C | 0.00 | 979,179 | 0 | 979,179 | 0 to 979.2 K |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Omega Fund IV, L.P. | 10% Owner | Buy | C | 0.00 | 979,179 | 0 | 979,179 | 0 to 979.2 K |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Atlas Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,525,253 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Atlas Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,838,230 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Atlas Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 12,925,244 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | Atlas Venture Fund VIII, L.P. | 10% Owner | Buy | C | 0.00 | 3,832,010 | 0 | 3,922,010 | 90 K to 3.9 M (+4,257.79 %) |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | C | 0.00 | 2,525,253 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | C | 0.00 | 5,838,230 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | C | 0.00 | 12,925,244 | 0 | 0 | |
| Jul 03 2018 | TBIO | Translate Bio, Inc ... | FORMELA JEAN FRANCOIS | Director | Buy | C | 0.00 | 3,832,010 | 0 | 3,922,010 | 90 K to 3.9 M (+4,257.79 %) |
| Jul 02 2018 | TBIO | Translate Bio, Inc ... | Shire Human Genetic Therapies, ... | 10% Owner | Buy | J | 0.00 | 183,619 | 0 | 7,078,945 | 6.9 M to 7.1 M (+2.66 %) |
| Jul 02 2018 | TBIO | Translate Bio, Inc ... | Shire Human Genetic Therapies, ... | 10% Owner | Buy | J | 0.00 | 183,619 | 0 | 7,078,945 | 6.9 M to 7.1 M (+2.66 %) |
Page: 1